ARCHIVES

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

This article is from The Cancer Letter archive.

Vol. 25 No. 13 | April 2, 1999

Download PDF Visit The Full Archive

Related Articles

Cancer Cases To Double By 2050, Annual Report Says

May 31, 2002

Guest Editorial: Omics Checklist Done, Now Create Business Model For Tests

February 7, 2013

Canadian NCI Plans Review Of National Breast Screening Study

February 24, 1995

In Brief: RFP Offers Patent Rights Instead Of Profit; ACS, NCI Plan More Joint Projects; BC Report Sept. 30

September 20, 1974

DCE Board Approves Recompetition Concepts

March 18, 1988

NIH Offers Curriculum Supplements For K-12

November 5, 1999